Information Provided By:
Fly News Breaks for May 8, 2015
REGN
May 8, 2015 | 07:24 EDT
Brean Capital raised its price target on Regeneron to $507 from $450 following its Q1 report, which saw Elyea sales beat expectations. Brean Capital cited the company's overall revenue beat and the affirmation of its guidance as reasons to reiterate its Buy rating on Regeneron shares.
News For REGN From the Last 2 Days
There are no results for your query REGN